Genentech names Hardy CEO

Genentech Inc. named Alexander Hardy CEO beginning March 1. Hardy, who joined the company in 2005, moved to parent company Roche (SIX:ROG; OTCQX:RHHBY) in 2014, where he most recently has been head of global product strategy of the pharmaceuticals

Read the full 390 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE